Abstract:Protein-targeted degradation is an emerging and promising therapeutic approach. The specificity of degradation and the maintenance of cellular homeostasis are determined by the interactions between E3 ubiquitin ligase and degradation signals, known as degrons. The human genome encodes over 600 E3 ligases; however, only a small number of targeted degron instances have been identified so far. In this study, we introduced DegronMD, an open knowledgebase designed for the investigation of degrons, their associated dysfunctional events, and drug responses. We revealed that degrons are evolutionarily conserved and tend to occur near the sites of protein translational modifications, particularly in the regions of disordered structure and higher solvent accessibility. Through pattern recognition and machine learning techniques, we constructed the degrome landscape across the human proteome, yielding over 18,000 new degrons for targeted protein degradation. Furthermore, dysfunction of degrons disrupts the degradation process and leads to the abnormal accumulation of proteins; this process is associated with various types of human cancers. Based on the estimated phenotypic changes induced by somatic mutations, we systematically quantified and assessed the impact of mutations on degron function in pan-cancers; these results helped to build a global mutational map on human degrome, including 89,318 actionable mutations that may induce the dysfunction of degrons and disrupt protein degradation pathways. Multiomics integrative analysis unveiled over 400 drug resistance events associated with the mutations in functional degrons. DegronMD, accessible at https://bioinfo.uth.edu/degronmd, is a useful resource to explore the biological mechanisms, infer protein degradation, and assist with drug discovery and design on degrons.

Degradation Bottlenecks and Resource Competition in Transiently and Stably Engineered Mammalian Cells

Identification of New Degrons in Streptococcus Mutans Reveals a Novel Strategy for Engineering Targeted, Controllable Proteolysis.

Degron tagging for rapid protein degradation in mice

Continuous evolution of compact protein degradation tags regulated by selective molecular glues

Tissue-Specific Knockdown of OMM Protein Via GFP Nanobody-Mediated Degradation

Degron-Controlled Protein Degradation in Escherichia coli : New Approaches and Parameters

Degradome analysis to identify direct protein substrates of small-molecule degraders

Engineering an SspB-mediated degron for novel controllable protein degradation

DegronMD: Leveraging Evolutionary and Structural Features for Deciphering Protein-Targeted Degradation, Mutations, and Drug Response to Degrons

Confounding factors in targeted degradation of short-lived proteins

Combination of AID2 and BromoTag expands the utility of degron-based protein knockdowns

Subunits of an E3 Ligase Complex as Degrons for Efficient Degradation of Cytosolic, Nuclear, and Membrane Proteins

Innovative, combinatorial and high-throughput approaches to degrader synthesis

Towards Targeted Protein Degradation in - depletion of the essential GroEL protein using CLIPPERs

Protein degrons and degradation: Exploring substrate recognition and pathway selection in plants

Setting the pace for degrons

"Reverse Degradomics", Monitoring of Proteolytic Trimming by Multi-Ce and Confocal Detection of Fluorescent Substrates and Reaction Products

Targeted protein degradation as a powerful research tool in basic biology and drug target discovery

Characterisation of high throughput screening outputs for small molecule degrader discovery

Engineering the auxin-inducible degron system for tunable control of organismal physiology

Microhomology-based CRISPR Tagging Tools for Protein Tracking, Purification, and Depletion